4/A//SEC Filing
Van Strydonck, Gerald E. 4/A
Accession 0000891839-20-000016
CIK 0001205922other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:32 PM ET
Size
5.8 KB
Accession
0000891839-20-000016
Insider Transaction Report
Form 4/AAmended
VACCINEX, INC.VCNX
Van Strydonck, Gerald E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-09-30+1,856→ 1,856 totalExercise: $7.17From: 2019-09-30Exp: 2029-09-27→ Common Stock (1,856 underlying)
Footnotes (2)
- [F1]The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date.
- [F2]Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001748247
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:32 PM ET
- Size
- 5.8 KB